GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection

NCT01209078 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Infections, Bacterial

Interventions

DRUG: GSK1322322
DRUG: Linezolid
DRUG: GSK1322322 placebo
DRUG: Linezolid placebo

Sponsor

GlaxoSmithKline